Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Giuseppe Curigliano(European Institute of Oncology), Uwe G. Liebert(University Hospital Leipzig), Corinne Faivre‐Finn(University of Manchester), Olivier Michielin(SIB Swiss Institute of Bioinformatics), Josep Tabernero(Deaconess Hospital), George Pentheroudakis(Hellenic Cooperative Oncology Group), John B.A.G. Haanen(Leiden University Medical Center), Eudald Felip(University of Ioannina), Fátima Cardoso(Breast Cancer Alliance), Paolo A. Ascierto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Ravindran Kanesvaran(University of Ioannina), S.B. Kim(Royal Marsden NHS Foundation Trust), Pasi A. Jänne(Harvard University), Jean-Yves Douillard(European Society for Medical Oncology), Pilar Garrido(Hospital Universitario Ramón y Cajal), Toni K. Choueiri(Harvard University), Dirk De Ruysscher(Maastro Clinic), Rob Glynne‐Jones(Mount Vernon Cancer Centre), Rafał Dziadziuszko(Gdańsk Medical University), Rebecca Dent(Duke-NUS Medical School), Karin Jordan(Heidelberg University), Elisabeth G.E. de Vries(Karolinska University Hospital), Nathan I. Cherny(Shaare Zedek Medical Center), Solange Peters(University Hospital of Lausanne), Alfredo Addeo, Susana Banerjee(Royal Marsden NHS Foundation Trust), Laurence Albigès(Université Paris-Saclay), Melvin L.K. Chua(Duke-NUS Medical School), Iris F. Chaberny(Institute of Medical Microbiology and Hygiene), E. de Azambuja(University of Ioannina), M.C. Garassino(Fondazione IRCCS Istituto Nazionale dei Tumori), Fabrice Barlési(Hôpital Nord), Carlos Caldas(University of Cambridge), Nicolas Girard(Institut Curie), F. Lordick(Leipzig University), E. Hamilton(University of Ioannina), Andrés Cervantes(INCLIVA Health Research Institute), Jean-Pascal Machiels(Cliniques Universitaires Saint-Luc), Carmen Criscitiello(University of Milan), V. Golfinopoulos(Universitat de València), Domenico D’Ugo(Agostino Gemelli University Polyclinic)
Cited by 313
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
The Immune Landscape of Cancer
|Immunity|2018|6.2k